Nonmetastatic pancreatic cancer: Improved survival with chemoradiotherapy > 40 Gy after systemic treatment

PURPOSE: The role of radiotherapy (RT) for nonmetastatic pancreatic cancer is still a matter of debate since randomized control trials have shown inconsistent results. The current retrospective single-institution study includes both resected and unresected patients with nonmetastasized pancreatic ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachmayer, Sebastian, Fastner, Gerd, Vaszi, Andrea, Iglseder, Wolfgang, Kopp, Peter, Holzinger, Josef, Dinnewitzer, Adam, Rinnerthaler, Gabriel, Gampenrieder, Simon Peter, Emmanuel, Klaus, Greil, Richard, Sedlmayer, Felix, Zehentmayr, Franz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008353/
https://www.ncbi.nlm.nih.gov/pubmed/29497791
http://dx.doi.org/10.1007/s00066-018-1281-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008353/
https://www.ncbi.nlm.nih.gov/pubmed/29497791
http://dx.doi.org/10.1007/s00066-018-1281-7

Ejemplares similares